Showing results (181-190 of 261) with videos related to
Sort By:
Pageof 27
Autoimmunity Reviews|October 20, 2018
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian expertsEnnio Giulio Favalli, Andrea Becciolini, Roberto Caporali, et al.Autoimmunity Reviews|May 20, 2026
Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort studyAnastasia Chioni, Corrado Campochiaro, Shiri Keret, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 29, 2024
Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patientsFederico Raimondi, Stefano Centanni, Fabrizio Luppi, et al.Clinical and Experimental Rheumatology|May 3, 2021
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitisSalvatore Scarpato, Marco Sebastiani, Luca Quartuccio, et al.Journal of Clinical Medicine|February 11, 2023
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory StudyVincenzo Venerito, Andreina Manfredi, Antonio Carletto, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|May 27, 2021
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?Meena Kalluri, Fabrizio Luppi, Ada Vancheri, et al.Journal of Clinical Medicine|December 23, 2022
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium"Fausto Salaffi, Cesare Siragusano, Alessandra Alciati, et al.Journal of Clinical Medicine|January 23, 2020
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective StudyGiulia Cassone, Andreina Manfredi, Fabiola Atzeni, et al.Life (Basel, Switzerland)|August 26, 2022
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian CentresPaolo Cameli, Paola Faverio, Katia Ferrari, et al.Clinical and Experimental Rheumatology|February 16, 2019
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEAFabiola Atzeni, Piercarlo Sarzi-Puttini, Marco Sebastiani, et al.Pageof 27